Levels of serum 25-hydroxy-vitamin D in benign and malignant breast masses

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 1, 2014, Pages 129-132

  Alipour, Sadaf ^a   Hadji, Maryam ^b   Hosseini, Ladan ^a   Omranipour, Ramesh ^b   Saberi, Azin ^a   Seifollahi, Akram ^a   Bayani, Leila ^a   Shirzad, Nooshin ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

25(OH) vitamin D; Breast mass; Breast neoplasm; Cancer; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN D;

ADULT; ARTICLE; BLOOD; BREAST TUMOR; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMAN; HYPERPLASIA; INTRADUCTAL CARCINOMA; LESIONS AND DEFECTS; MAMMARY GLAND; MASTITIS; PAGET NIPPLE DISEASE; PAPILLOMA; PATHOLOGY; VITAMIN D DEFICIENCY;

ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DILATATION, PATHOLOGIC; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMANS; HYPERPLASIA; MAMMARY GLANDS, HUMAN; MASTITIS; PAPILLOMA; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84894035934     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.1.129     Document Type: Article

References (30)

1. Bener A, El Ayoubi HR (2012). The role of vitamin D deficiency and osteoporosis in breast cancer. Int J Rheum Dis, 15, 554-61.
2. Bilinski K, Boyages J (2013). Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study. Breast Cancer Res Treat, 137, 599-607.
3. Chlebowski RT, Johnson KC, Kooperberg C, et al (2008). Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst, 100, 1581-91.
4. Chlebowski RT (2011). Vitamin D and breast cancer: interpreting current evidence. Breast Cancer Res, 13, 217.
5. Chlebowski RT (2013). Vitamin D and breast cancer incidence and outcome. Anticancer Agents Med Chem, 13, 98-106.
6. Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA (2011). Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med, 155, 827-38.
7. Eliassen AH, Spiegelman D, Hollis BW, et al (2011). Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II. Breast Cancer Res, 13, 50.
8. Engel P, Fagherazzi G, Boutten A, Dupre T, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F (2010). Serum 25(OH) vitamin D and risk of breast cancer: a nested case-control study from the French E3N cohort. Cancer Epidemiol Biomarkers Prev, 19, 2341-50.
9. Engel P, Fagherazzi G, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F (2011). Joint effects of dietary vitamin D and sun exposure on breast cancer risk: results from the French E3N cohort. Cancer Epidemiol Biomarkers Prev, 20, 187-98.
10. Fedirko V, Torres-Mejia G, Ortega-Olvera C, et al (2012). Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women. Cancer Causes Control, 23, 1149-62.
11. Freedman DM, Chang SC, Falk RT, et al (2008). Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev, 17, 889-94.
12. Grant WB (2010). Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers. J Photochem Photobiol B, 101, 130-6.
13. Gupta D, Vashi PG, Trukova K, Lis CG, Lammersfeld CA (2011). Prevalence of serum vitamin D deficiency and insufficiency in cancer: Review of the epidemiological literature. Exp Ther Med, 2, 181-93.
14. Harirchi I, Kolahdoozan S, Karbakhsh M, et al (2011). Twenty years of breast cancer in Iran: downstaging without a formal screening program. Ann Oncol, 22, 93-7.
15. Jacobs ET, Thomson CA, Flatt SW, et al (2011). Vitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL) Study. Am J Clin Nutr, 93, 108-17.
16. Kermani IA, Kojidi HT, Gharamaleki JV, et al (2011). Association of serum level of 25 hydroxy-vitamin D with prognostic factors for breast cancer. Asian Pac J Cancer Prev, 12, 1381-4.
17. Lee MS, Huang YC, Wahlqvist ML, et al (2011). Vitamin D decreases risk of breast cancer in premenopausal women of normal weight in subtropical taiwan. J Epidemiol, 21, 87-94.
18. Lippolis JD, Reinhardt TA, Sacco RA, Nonnecke BJ, Nelson CD (2011). Treatment of an intramammary bacterial infection with 25-hydroxyvitamin D(3). PLoS One, 6, 25479.
19. Lopes N, Paredes J, Costa JL, Ylstra B, Schmitt F. (2012). Vitamin D and the mammary gland: a review on its role in normal development and breast cancer. Breast Cancer Res, 14, 211.
20. Mohr SB, Gorham ED, Alcaraz JE, et al (2011). Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis. Anticancer Res, 31, 2939-48.
21. Mousavi SM, Montazeri A, Mohagheghi MA, et al (2007). Breast cancer in Iran: an epidemiological review. Breast J, 13, 383-91.
22. Ordonez-Mena JM, Schottker B, Haug U, et al (2013). Serum 25-Hydroxyvitamin D and Cancer Risk in Older Adults: Results from a Large German Prospective Cohort Study. Cancer Epidemiol Biomarkers Prev, 22, 905-16
23. Pazdiora P, Svobodova S, Fuchsova R, et al (2011). Vitamin D in colorectal, breast, prostate and lung cancer: a pilot study. Anticancer Res, 31, 3619-21.
24. Peppone LJ, Rickles AS, Janelsins MC, Insalaco MR, Skinner KA (2012). The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels. Ann Surg Oncol, 19, 2590-9.
25. Rohan TE, Negassa A, Chlebowski RT, et al (2009). A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease. Breast Cancer Res Treat, 116, 339-50.
26. Shamsi U, Khan S, Usman S, Soomro S, Azam I (2013). A multicenter matched case control study of breast cancer risk factors among women in Karachi, Pakistan. Asian Pac J Cancer Prev, 14, 183-8.
27. Shao T, Klein P, Grossbard ML (2012). Vitamin D and breast cancer. Oncologist, 17, 36-45.
28. Su X, Colditz GA, Collins LC, et al (2012). Adolescent intakes of vitamin D and calcium and incidence of proliferative benign breast disease. Breast Cancer Res Treat, 134, 783-91.
29. Vobecky J, Simard A, Vobecky JS, et al (1993). Nutritional profile of women with fibrocystic breast disease. Int J Epidemiol, 22, 989-99.
30. Yao S, Sucheston LE, Millen AE, Johnson CS, et al (2011). Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study. PLoS One, 6, 17251.